Hilal Ayoglu

Dr. Hilal Ayoglu


Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2008 in Journal of Clinical Anesthesia
Verified
Journal Article
Closed access
HAHilal Ayoglu
Hilal Ayoglu
OYOsman Yapakci
Osman Yapakci
MUMehmet Birol Ugur
Mehmet Birol Ugur
LULokman Uzun
Lokman Uzun
HAHanife Altunkaya
Hanife Altunkaya
IOIsil Ozkocak
Isil Ozkocak

1 June 2007 in European Journal of Anaesthesiology
Verified
Journal Article
Closed access
HAHilal Ayoglu
Hilal Ayoglu
HAH. Altunkaya
H. Altunkaya
YÖY. Özer
Y. Özer
OYO. Yapakç
O. Yapakç
GÇG. Çukdar
G. Çukdar
IÖI. Özkoçak
I. Özkoçak
This prospective, double-blind, randomized, placebo-controlled study was designed to determine the efficacy of dexmedetomidine compared with lidocaine in reducing the pain of propofol and rocuronium injection pain. One hundred and fifty patients, scheduled for elective surgery with general anaesthesia, were divided into five groups: saline (Group 1), dexmedetomidine 0.25 microg kg(-1) (Group 2), lidocaine 0.5 mg kg(-1) (Group 3), dexmedetomidine 0.25 microg kg(-1) plus lidocaine 0.25 mg kg(-1) (Group 4) or dexmedetomidine 0.25 microg kg(-1) plus lidocaine 0.5 mg kg(-1) (Group 5) were administered at a rate of 0.5 mL s(-1) after tourniquet application. The occlusion was released after 1 min and 5 mL of propofol was injected over 20 s. Pain was evaluated by use of a 10-point verbal analogue scale. Then, the rest of the induction dose of propofol, 3 mL of saline bolus and 0.6 mg kg(-1) of rocuronium, was injected. The response to injection of rocuronium was assessed with a four-point scale (0-3). Groups 1 and 2 were found to have higher propofol injection pain scores than Groups 3, 4 and 5 (P < 0.05). When the study groups were compared according to the overall incidence of withdrawal movements due to rocuronium (1 response) in Groups 1, 2, 3, 4 and 5, they were different (86.7%, 60%, 36.7%, 50% and 40%, respectively) (P < 0.05). Except Group 1, there was no significant difference between the groups according to incidence of withdrawal movement after rocuronium injection (P = 0.325). Pretreatment with dexmedetomidine is not effective in reducing injection pain of propofol, but may attenuate the hand withdrawal associated to rocuronium, as lidocaine does.

1 June 2010 in Journal of Clinical Neuroscience
Verified
Journal Article
Closed access
HAHilal Ayoglu
Hilal Ayoglu
SGSanser Gul
Sanser Gul
VHVolkan Hanci
Volkan Hanci
BBBurak Bahadir
Burak Bahadir
SBSibel Bektas
Sibel Bektas
BABektas Acikgoz
Bektas Acikgoz

4 November 2008 in Archives of orthopaedic and trauma surgery
Verified
Journal Article
Closed access
PDF file
HAHilal Ayoglu
Hilal Ayoglu
HAHanife Altunkaya
Hanife Altunkaya
ABAhmet Bayar
Ahmet Bayar
ITIsil Ozkocak Turan
Isil Ozkocak Turan
YOYetkin Ozer
Yetkin Ozer
AEAhmet Ege
Ahmet Ege

13 October 2012 in The Kaohsiung Journal of Medical Sciences
Verified
Journal Article
Open access
EBEvrim Bostankolu
Evrim Bostankolu
HAHilal Ayoglu
Hilal Ayoglu
SYSerhan Yurtlu
Serhan Yurtlu
RORahsan Dilek Okyay
Rahsan Dilek Okyay
GEGülay Erdogan
Gülay Erdogan
ITIsil Ozkocak Turan
Isil Ozkocak Turan
Ischemia reperfusion injury causes the release of free oxygen radicals. Free oxygen radicals initiate the production of toxic metabolites, such as malondialdehyde (MDA), through the lipid peroxidation of cellular membranes. Following lipid peroxidation, the antioxidant enzyme system is activated against reactive oxygen species (ROS) and attempts to protect cells from oxidative damage. There is a balance between the scavenging capacity of antioxidant enzymes and ROS. Because of this balance, the total antioxidant capacity (TAC) measurement is a sensitive indicator of the overall protective effects of the antioxidants. Alpha2 receptor agonists are effective in preventing hemodynamic reactions during extremity surgeries by preventing the release of catecholamines secondary to tourniquet application. They have also been shown to possess preventive effects in various ischemia‐reperfusion injury models. In our study, we examined the effects of dexmedetomidine on tourniquet‐induced ischemia‐reperfusion injury in lower extremity surgeries performed under general anesthesia. The effects of dexmedetomidine were measured with serum MDA and TAC levels. We studied 60 adult American Society of Anesthesiologists (ASA) physical status I or II patients undergoing one‐sided lower extremity surgery with tourniquet. The patients were randomly divided into two groups. Group D was administered a dexmedetomidine infusion at a rate of 0.1 μg/kg/minute−1 for 10 minutes prior to induction and then at 0.7 μg/kg/hour−1 until 10 minutes before the end of the operation. The control group (Group C) received a saline infusion of the same amount and for the same period of time. General anesthesia was induced with thiopental, fentanyl, and rocuronium and maintained with nitrous oxide and sevoflurane in both groups. Venous blood samples were obtained before the administration of the study drugs (basal) at 1 minute before tourniquet release and at 5 and 20 minutes after tourniquet release (ATR). In both groups, MDA levels decreased at 5 and 20 minutes ATR when compared with the basal values (p < 0.05). TAC levels decreased at 1 and 5 minutes ATR and then returned to basal values at 20 minutes ATR (p < 0.05). In reference to the prevention of lipid peroxidation in tourniquet‐induced ischemia‐reperfusion injury, the results from the two groups in our study showed that dexmedetomidine did not have an additional protective role during routine general anesthesia.

1 September 2007 in British Journal of Anaesthesia
Verified
Journal Article
Open access
PDF file
HAHilal Ayoglu
Hilal Ayoglu
HAH. Altunkaya
H. Altunkaya
YOY. Ozer
Y. Ozer
OYO. Yapakci
O. Yapakci
IOI. Ozkocak
I. Ozkocak
SUS. H. Ugurbas
S. H. Ugurbas
Editor—Regional anaesthesia for ophthalmic surgical procedures provides an immobile and clear operative field, low-normal intraocular pressure, cardiovascular stability, and good cooperation between the patient and the surgical team.1 Although akinesia and analgesia can be achieved with a regional block, appropriate sedation may lower the intraocular pressure and pain on injection, prevent the hypertensive response to anxiety and local anaesthetic injection, and provide patient comfort. Dexmedetomidine is a selective and specific α2-adrenoceptor agonist, which has beneficial sedative effects for premedication and intensive care sedation procedures and also beneficial effects on intraocular pressure during eye surgery.2 We have investigated the efficacy of dexmedetomidine during cataract surgery under regional anaesthesia.